Literature DB >> 10724036

Control of the functional activity of an antisense RNA by a tetracycline-responsive derivative of the human U6 snRNA promoter.

J Ohkawa1, K Taira.   

Abstract

In an effort to develop a regulatable derivative of the promoter of the human gene for U6 snRNA, we generated several constructs composed of the human U6 snRNA promoter and sequences derived from the gene for the tetracycline operator of a prokaryotic tetracycline resistance transposon. One of the constructs had strong transcriptional activity in the presence of tetracycline that was equivalent to 80% of the activity of the wild-type promoter. Furthermore, the transcriptional activity was almost completely repressed in the absence of tetracycline. Transcriptional activity became detectable within 4 hr after the addition of tetracycline to the culture medium. We used this system to control the functional activity of an antisense RNA for a chimeric gene derived from genes for the epidermal growth factor receptor (EGFR) and green fluorescent protein (GFP). A plasmid that expressed the chimeric gene and a plasmid that expressed the antisense RNA under the control of the inducible U6 promoter were used to cotransfect HeLa cells that were producing the tetracycline repressor protein (Tet R). Addition of tetracycline to the culture medium 12 hr after transfection resulted in the almost complete disappearance of the fluorescent signal due to the chimeric protein within 24 hr. Our results suggest that this expression system might be a useful tool for controlling the expression of functional RNAs, such as aptamers and antisense RNAs, both in basic research and in gene therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10724036     DOI: 10.1089/10430340050015761

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  24 in total

1.  Reduction of target gene expression by a modified U1 snRNA.

Authors:  S A Beckley; P Liu; M L Stover; S I Gunderson; A C Lichtler; D W Rowe
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Inducible shRNA expression for application in a prostate cancer mouse model.

Authors:  Frank Czauderna; Ansgar Santel; Michael Hinz; Melanie Fechtner; Birgit Durieux; Gerald Fisch; Frauke Leenders; Wolfgang Arnold; Klaus Giese; Anke Klippel; Jörg Kaufmann
Journal:  Nucleic Acids Res       Date:  2003-11-01       Impact factor: 16.971

3.  Functional studies of the PI(3)-kinase signalling pathway employing synthetic and expressed siRNA.

Authors:  Frank Czauderna; Melanie Fechtner; Hüseyin Aygün; Wolfgang Arnold; Anke Klippel; Klaus Giese; Jörg Kaufmann
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

4.  Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development.

Authors:  Jeffrey R Skaar; Takehiro Arai; James A DeCaprio
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

5.  A more efficient RNAi inducible system for tight regulation of gene expression in mammalian cells and xenograft animals.

Authors:  Jing Zhang; Cuiying Wang; Ning Ke; Josh Bliesath; John Chionis; Qiuchen S He; Qi-Xiang Li; Jon E Chatterton; Flossie Wong-Staal; Demin Zhou
Journal:  RNA       Date:  2007-07-06       Impact factor: 4.942

6.  Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy.

Authors:  Y C Tang; Y Li; G X Qian
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

7.  A tightly regulated Pol III promoter for synthesis of miRNA genes in tandem.

Authors:  Hongxia Zhou; Cao Huang; Xu Gang Xia
Journal:  Biochim Biophys Acta       Date:  2008-04-07

8.  A novel short hairpin RNA (shRNA) expression system promotes Sox9-dependent gene silencing.

Authors:  James R Gilbert; Christopher S Adams; Irving M Shapiro; Noreen J Hickok
Journal:  Plasmid       Date:  2009-04-21       Impact factor: 3.466

9.  Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector.

Authors:  Marc van de Wetering; Irma Oving; Vanesa Muncan; Menno Tjon Pon Fong; Helen Brantjes; Dik van Leenen; Frank C P Holstege; Thijn R Brummelkamp; Reuven Agami; Hans Clevers
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

10.  Establishment of conditional vectors for hairpin siRNA knockdowns.

Authors:  Shiro Matsukura; Peter A Jones; Daiya Takai
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.